| Dr Claude F Varner Jr, MD | |
|
1265 Union Ave, Memphis, TN 38104-3415 | |
| (901) 291-2400 | |
| Not Available |
| Full Name | Dr Claude F Varner Jr |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1265 Union Ave, Memphis, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053313049 | NPI | - | NPPES |
| 3019798 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 5776 (Tennessee) | Primary |
| Entity Name | Carr, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548677610 PECOS PAC ID: 1850512153 Enrollment ID: O20141030001974 |
News Archive
ALS is a very severe neurodegenerative disease in which nerve cells in the spinal cord controlling muscles and movement slowly die. There is no effective treatment and the average life expectancy after being diagnosed with ALS is usually short. Because of this, new knowledge about the disease is urgently needed.
In the first study of its kind, Penn researchers have shown how an anti-diabetic drug can have variable effects depending on small natural differences in DNA sequence between individuals. Mitchell Lazar, MD, PhD, Raymond Soccio, MD, PhD, and colleagues at the Perelman School of Medicine at the University of Pennsylvania, aim to apply this knowledge to develop personalized approaches to treating diabetes and other metabolic disorders.
The House voted 235-189 on Saturday to pass legislation that "would fund government operations through Sept. 30, the end of fiscal 2011, while sharply reducing spending across a wide swath of federal agencies and programs," CQ reports. "Most spending levels under the bill would be based on fiscal 2010 levels, less eliminations, reductions and rescissions totaling roughly $61.5 billion. The measure would provide $99.6 billion less than President Obama sought for fiscal 2011," the news service writes (Weyl, 2/19).
Profil Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, and Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, jointly announced today a strategic alliance to offer Profil Institute customers use of Rosa's modeling technology to simulate disease physiology, drug action, patient variability, and trial outcomes for their early phase clinical development programs.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Claude F Varner Jr, MD 8010 Stage Hills Blvd, Bartlett, TN 38133-4032 Ph: (901) 291-2427 | Dr Claude F Varner Jr, MD 1265 Union Ave, Memphis, TN 38104-3415 Ph: (901) 291-2400 |
News Archive
ALS is a very severe neurodegenerative disease in which nerve cells in the spinal cord controlling muscles and movement slowly die. There is no effective treatment and the average life expectancy after being diagnosed with ALS is usually short. Because of this, new knowledge about the disease is urgently needed.
In the first study of its kind, Penn researchers have shown how an anti-diabetic drug can have variable effects depending on small natural differences in DNA sequence between individuals. Mitchell Lazar, MD, PhD, Raymond Soccio, MD, PhD, and colleagues at the Perelman School of Medicine at the University of Pennsylvania, aim to apply this knowledge to develop personalized approaches to treating diabetes and other metabolic disorders.
The House voted 235-189 on Saturday to pass legislation that "would fund government operations through Sept. 30, the end of fiscal 2011, while sharply reducing spending across a wide swath of federal agencies and programs," CQ reports. "Most spending levels under the bill would be based on fiscal 2010 levels, less eliminations, reductions and rescissions totaling roughly $61.5 billion. The measure would provide $99.6 billion less than President Obama sought for fiscal 2011," the news service writes (Weyl, 2/19).
Profil Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, and Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, jointly announced today a strategic alliance to offer Profil Institute customers use of Rosa's modeling technology to simulate disease physiology, drug action, patient variability, and trial outcomes for their early phase clinical development programs.
› Verified 7 days ago
Dr. Lori Rae Holtzman, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2565 Horizon Lake Dr Ste 114, Memphis, TN 38133 Phone: 901-350-2639 Fax: 901-249-4563 | |
Dr. Michael Jerome Washington, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1265 Union Ave, Memphis, TN 38104 Phone: 901-291-2400 | |
Dr. Anthony C Moretta, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 505 Tennessee St Apt 304, Memphis, TN 38103 Phone: 901-626-9560 | |
Victoria Jean Vorholt, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 920 Madison Ave Ste 447, Memphis, TN 38103 Phone: 615-396-6449 | |
Dr. Clyde M Brown, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3960 New Covington Pike, Memphis, TN 38128 Phone: 901-516-5211 | |
Jason Taylor Silberman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6019 Walnut Grove Rd, Memphis, TN 38120 Phone: 901-226-3010 Fax: 901-226-1216 |